Brian Armstrong’s NewLimit Raises $130 Million for Anti-Aging Research

By: bitdegree|2025/05/07 15:30:02
0
Share
copy
Ace quick missions & earn crypto rewards while gaining real-world Web3 skills. Participate Now ! A biotech company co-founded by Coinbase $1.58B CEO Brian Armstrong, NewLimit , has secured $130 million in new funding . The funding round, called Series B, was led by Kleiner Perkins , according to a May 6 statement . New investors joining in this round include former GitHub CEO Nat Friedman, Daniel Gross, who used to lead machine learning efforts at Apple, and Khosla Ventures. Did you know? Subscribe - We publish new crypto explainer videos every week! What is Solana in Crypto? (Beginner-Friendly Animation) SUBSCRIBE Armstrong started NewLimit with Blake Byers, a former GV partner, and stem cell researcher Jacob Kimmel. The company is working on therapies that aim to extend the number of healthy years a person can live . The approach focuses on changing how cells work by adjusting the epigenome, which affects cell behavior without altering the DNA. NewLimit believes that aging is not just a natural process but a key factor behind many major diseases. The company explained that while aging was once thought to be permanent, new research in epigenetic reprogramming suggests it can be changed. The company uses a combination of genomics and artificial intelligence (AI) . Its main tool, called the Discovery Engine , tests thousands of ways to adjust human cells and studies the results . Machine learning models then help decide which changes to test next. In a statement, NewLimit stated, "Our bet is that this combination of AI and scaled genomics can unlock medicines that give each of us more healthy years". Recently, Neuralink, the brain tech company founded by Elon Musk, invited people to participate in its global brain chip trials. What is the aim of the trial? Read the full story . Enjoyed this article? Share it with your friends!

You may also like

2025 South Korea CEX Listing Post-Mortem: Investing in New Coins = 70% Loss?

The 2025 South Korean exchange's new token listing performance is structurally similar to Binance's, with no significant differences.

BIP-360 Analysis: Bitcoin's First Step Towards Quantum Immunity, But Why Only the "First Step"?

This article explains how BIP-360 reshapes Bitcoin's quantum defense strategy, analyzes its enhancements, and discusses why it has not yet achieved full post-quantum security.

50 million USDT exchanged for 35,000 USD AAVE: How did the disaster happen? Who should we blame?

Due to a fatal flaw in the transaction path, a $50 million DeFi operation was executed with almost zero protection, resulting in nearly the entire amount of funds evaporating in a tiny liquidity pool.

The Cryptographic Past of the Middle East

Reality is often more exciting than fiction.

Resolving the Intergenerational Prisoner's Dilemma: The Inevitable Path of Nomadic Capital Bitcoin

When the baby boomer generation collectively sells off, who will become the "greater fool" in the next round of asset crashes?

Who Will Control AI? Why Decentralized AI May Be the Only Alternative to Government and Big Tech

AI has become critical infrastructure, and governments and corporations are competing to control it. Centralized development and regulation are entrenching existing power structures. The Web3 community is building a decentralized alternative — distributed compute, token incentives, and community governance — before that window closes.

Popular coins

Latest Crypto News

Read more